IDEAYA Biosciences, Inc. is headquartered in South San Francisco, California.
Our mailing address is:
IDEAYA Biosciences, Inc.
7000 Shoreline Court, Suite 350
South San Francisco, CA 94080
IDEAYA is incorporated in the State of Delaware.
IDEAYA’s fiscal year is from January 1st to December 31st.
IDEAYA stock is traded on NASDAQ under the ticker symbol IDYA. Our CUSIP number is 45166A 102.
IDEAYA enacted a 10.2564 : 1 reverse stock split directly before its initial public offering on May 22, 2019.
IDEAYA has engaged American Stock Transfer & Trust Company, LLC as transfer agent and registrar. The transfer agent and registrar’s address is 6201 15th Avenue, Brooklyn, NY 11219.
For questions related to your stock holdings, please contact American Stock Transfer & Trust Company, LLC here.
IDEAYA’s corporate counsel is Latham & Watkins, LLP.
IDEAYA’s latest news releases can be found here.
Documents filed with the SEC by IDEAYA can be found here or through the SEC’s website at www.sec.gov.
Information and profiles for IDEAYA’s Leadership Team can be found here.
Information and profiles for IDEAYA’S Board of Directors can be found here.
For more information about IDEAYA, please visit our website, www.ideayabio.com.
Information about IDEAYA’s earnings release schedule can be found here.
If you would like to receive email alerts about IDEAYA, please visit the “Alerts” section of our website here.
Investor inquiries can be directed to firstname.lastname@example.org.
Analyst coverage for IDEAYA is provided by each of JP Morgan, Citi and Jeffries, which led our initial public offering, as well as by other analysts, as noted on our website here.
A current copy of IDEAYA’s annual report and proxy can be found here or through the SEC’s website at www.sec.gov.
We anticipate IDEAYA will hold its annual meeting in June of each year; please refer to upcoming events in the investor section of our website here.